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Abstract
Two brothers in their fifties presented with a medical history of suspected fungal allergy, allergic bronchopulmonary
aspergillosis, alveolitis, and invasive aspergillosis and pulmonary fistula, respectively. Eventually, after a delay of 50 years,
chronic granulomatous disease (CGD) was diagnosed in the index patient. We found a new splice mutation in the NCF2
(p67-phox) gene, c.1000+2TRG, that led to several splice products one of which lacked exons 11 and 12. This deletion was
in frame and allowed for remarkable residual NADPH oxidase activity as determined by transduction experiments using a
retroviral vector. We conclude that p67-phox which lacks the 34 amino acids encoded by the two exons can still exert
considerable functional activity. This activity can partially explain the long-term survival of the patients without adequate
diagnosis and treatment, but could not prevent progressing lung damage.
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Introduction
Chronic granulomatous disease (CGD) is caused by inherited
defects in the NADPH oxidase multienzyme complex. This rare
disorder is associated with life-threatening opportunistic infections
and dysregulated inflammation, often accompanied by granuloma
formation even in the absence of detectable infections [1–6]. In
most cases, CGD manifests itself before the third year of life, but a
delayed diagnosis, especially in patients with residual NADPH
oxidase activity, is quite common [3,5]. Indeed, more and more
cases emerge with manifestations in adulthood. In such cases, the
diagnosis is often delayed for years or even decades [6–10]
preventing adequate treatment.
In addition to infections, older CGD patients frequently suffer
from various autoinflammatory symptoms. They need regular
medical checkups [11], prophylactic and interventional antimi-
crobial and/or immunosuppressive treatment [6,12,13], and their
disorder may be corrected by hematopoietic stem cell transplan-
tation [1,14]. Gene therapy may be a future therapeutic option
[15].
The phagocyte NADPH oxidase is needed for appropriate
microbial killing and regulation of inflammation. CGD is caused
by mutations affecting the expression or function of one out of four
components of this enzyme complex [3]. These components are
gp91-phox (also referred to as NOX2), p22-phox, p47-phox, and
p67-phox, (MIM#s 608515, 233710; -phox, phagocyte oxidase).
Rac2 [16], p40-phox, and severe G6PD deficiency also cause
CGD-like diseases, but differ from the classical form. In about two-
thirds of all CGD cases, mutations are found in the X-
chromosomal CYBB gene encoding gp91-phox/NOX2. The
genetic aberrations are family-specific and comprise a wide range
of mutation types [17]. Mutations are also family-specific in
autosomal-recessive p22-phox [18] and in p67-phox [19] defi-
ciencies, which are much rarer than the X-linked form (each 5% of
all CGD cases). In contrast, autosomal recessive p47-phox
deficiency (25% of all CGD cases [19,20]) is mostly due to
recombination events between the NCF1 gene and one out of two
highly homologous pseudogenes, thus leading to the same GT
deletion at the beginning of exon 2 in 80–90% of all p47-phox–
deficient CGD patients.
In healthy individuals, the p67-phox protein combines with
other components of the NADPH oxidase to form the fully-
functional reactive oxygen species (ROS)-producing enzyme
complex [21,22]. The SH3 domain close to the C-terminal end
of p67-phox interacts with the proline-rich region (PRR) of p47-
phox, the PB1 domain links p67-phox to p40-phox, and the
tetratricopeptide repeat (TPR) region of p67-phox domain binds
Rac-GTP [21,23].
Here we describe a new splice mutation in NCF2 (p67-phox)
leading to residual NADPH oxidase activity, thereby contributing
to an extremely late diagnosis of CGD in adulthood.
Results
Case reports
At age 8 years, the index patient was first hospitalized for six
months with a fungal pneumonia after threshing of mouldy grain.
Thirty years later, he had another fungal pneumonia caused by
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34296non-specified Aspergillus. Thereafter, he suffered from recurrent
episodes of dyspnea mostly after exposure to moulding organic
material (Table 1). These episodes were interpreted as fungal
allergy, allergic bronchopulmonary aspergillosis or hypersensitivity
pneumonitis and treated with steroids and antimycotic drugs. At
age 48 years a persisting pulmonary fistula and local infiltration
with Aspergillus fumigatus prompted lobectomy of the lower left lung
lobe. Between age 54 and 56 years two invasive pulmonary
Aspergillus infections of the right and left upper lobe and a fistula of
the left upper lobe were treated by dissection of the affected lung
parts. Prolonged immunosuppression by steroids was thought to be
the reason for these complications. However, after discontinuation
the patient experienced a rapid deterioration of his pulmonary
function requiring continuous oxygen supplementation and
causing cor pulmonale.
The 53 year-old brother of the 58 year-old index patient had to
give up his profession as a beer brewer due to recurrent episodes of
dyspnea after exposure to moulding organic materials. These
episodes were thought to be of allergic etiology. Furthermore, a
liver abscess caused by Staph. aureus was drained. (Table 1,
bottom).
Laboratorial findings
To diagnose CGD, reactive oxygen species (ROS) were
measured using the DHR assay and lucigenine enhanced
chemoluminescence (CL) [24]. Both tests showed small amounts
of residual NADPH oxidase activity (Fig. 1, A; Table 2).
Neutrophils and monocytes from the index patient expressed
cytochrome b558 normally as revealed by staining with the mab
7D5 and flow cytometry (Fig. 1, B). In the majority of CGD
cases, leukocytes are cytochrome b558 negative when mutations
are located in the membrane associated components gp91-phox
(CYBB) and p22-phox (CYBA) of the NADPH oxidase, but always
positive when the mutations are located in the cytosolic factors of
this enzyme. Consequently, we focussed on these factors and
sequenced exon 2 of the NCF1 (p47-phox) gene to check for the
hot spot mutation c.75_76delGT [20], and the NCF2 gene on the
genomic level.
The index patient and his brother were normal at the p47-phox
hot spot, but homozygous for a splice mutation (c.1000+2TRG)
downstream of exon 11 in NCF2. This mutation destroyed the
splice consensus sequence. Accordingly, several deranged splice
products, but no normally spliced NCF2 cDNA could be detected
by separation on an agarose gel (data not shown). cDNA strands of
different length were cut out and sequenced. However, many
bands consisted of heterodimers of different splice products
complicating the analysis. As expected, exon 11 was always
skipped and one main splice product lacked exon 11, but was
otherwise normal.
However, NCF2 mRNA without exon 11 could not account for
the residual NADPH oxidase activity because this exon skipping
deranged the sequence by setting it out of frame (Fig. 2, B).
Further search raised suspicion for a splice product lacking two
exons, 11 and 12 (p67delex11,12) and thereby 34 triplets. The
presence of this splice product was confirmed by two PCR
approaches, one using a forward primer located in exon 10 with
Table 1. Overview over medical histories.
Medical history of patient 1; 58 years old at diagnosis of CGD
Age (years) Symptoms Therapy
Before 8 * Eczema, recurrent tonsillitis Tonsillectomy
8* Fungal pneumonia Antimycotics for 6 months
38 (and later) Suspected pulmonary aspergillosis Intermittent treatment with itraconazole and corticosteroids
38 Documentation of chronic inflammatory lung disease Starting long term treatment with corticosteroids, further
intermittent treatments with antimycotics, especially itraconazole
39 Suspected hypersensitivity pneumonitis
47 Suspected allergic bronchopulmonale aspergillosis
48 Lung biopsy complicated by fistula formation, Aspergillus fumigatus found Resection of left lower lobe
51–54 Recurrent pulmonary aspergillosis At age 54: Resection of right upper lobe infiltrated by Aspergillus
fumigatus
56 Aspergillosis of left upper lobe Resection of left segments 1–3, complicated by fistula formation
56 Unspecified pneumonia Addition of antibiotics
58 Pulmonary deterioration after discontinuation of corticosteroids: diagnosis
of pulmonary hypertension and partial respiratory insufficiency
Home oxygen supply
Medical history of patient 2; 53 years old at diagnosis of CGD
Age (years) Symptoms Therapy
Whole
childhood*
Recurrent skin abscesses
3* Fungal pneumonia Antimycotics for 6 months
41–48 Recurrent dyspnea after grain dust exposure (ale brewer), suspected exogen
allergic alveolitis
Intermittent treatment with corticosteroids
48 Official recognition of ‘‘severe grain dust allergy’’ as work-related disease
48 Liver abscess by Staph. aureus Drainage
*The medical histories of childhood are slightly vague because no documents were available, but rely on what the patients and their mother remember.
doi:10.1371/journal.pone.0034296.t001
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second PCR using a reverse primer in exon 13 with an overlap
into exon 10 and an upstream forward primer (PCR 1, 2, Table 3,
Fig. 3). Both PCR approaches gave strong bands when applied to
patient cDNA, but gave no amplimer when applied to normal
cDNA Fig. 3). The splice product p67delex11,12 was the only one
found to be in frame (Fig. 2).
In order to confirm that p67delex11,12 could indeed lead to a
functional NADPH oxidase, we inserted a p67delex11,12-cDNA
into a retroviral vector and transduced K562 cells expressing all
NADPH oxidase components except p67-phox (model p67-CGD
cells). As shown in Table 4 the NADPH oxidase multi-enzyme-
complex that contained p67delex11,12 instead of complete p67-
phox could still produce remarkable amounts of ROS (approxi-
mately 10% superoxide compared to the wild-type form) after
stimulation with phorbol myristate acetate (PMA).
IFNc has been described to influence splicing and nuclear
export of normal transcripts in a case of gp91-phox deficient CGD
caused by a splice mutation [25]. To analyze if IFNc could also be
effective in our patients, we incubated EBV-transformed B cells
from the index patient with 10 or 20 ng/ml IFNc [25], but found
no improvement in the production of ROS (data not shown).
Discussion
We report two brothers who suffered from symptoms typical for
CGD, starting with the first manifestation of their disorder in
childhood (Table 1). The extreme delay of 50 years between the
first symptom and the diagnosis of CGD in the index patient may
be explained by the severe inflammatory lung disease, a condition
erroneously not considered to be typical for primary immunode-
ficiency. Unfortunately, physicians other than specialized pedia-
tricians are seldom familiar with CGD, which is a rare disorder
(approx. 1 in 200,000 newborns).
The prognosis of CGD patients clearly depends on residual
NADPH oxidase activity [26]. However, there are other
environmental and genetic effects that also influence the outcome
[27]. The ROS production of neutrophils from our patients was
very low. Nevertheless, it has most probably helped to slow down
the progression of CGD complications.
The patients were homozygous for the new disease-causing
splice mutation (c.1000+2TRG) and their parents therefore most
probably consanguineous. The mutation could not easily explain
the residual NADPH oxidase activity. It predicts skipping of exon
11 that was found indeed, but sets the downstream mRNA out of
frame. Splice mutations often generate several aberrant splice
products for example by indirectly activating cryptic splice sites.
Figure 1. Production of small amounts of ROS (hydrogenperoxide) by neutrophils from the index patient (A, straight line) and normal
expression of cytochrome b558 (consisting of gp91-phox and p22-phox, B). A, DHR assay; no stimulation, gray area; activation with PMA,
patient’s cells, straight line; cells from a healthy control donor, dotted line; the residual NADPH oxidase activity was reproducible in different labs. B,
cell staining with the mab 7D5; gray area, isotype control; lines as in A. Abscissa, green fluorescence.
doi:10.1371/journal.pone.0034296.g001
Table 2. Residual ROS (superoxide) production by 10
5
neutrophils.
CL Indexpatient Healthy donor
unstimulated 1.5610
6 2.8610
6
PMA 2.8610
6 28.0610
6
Zymosane A 3.7610
6 21.0610
6
CL: lucigenine enhanced chemoluminescence, arbitrary light units in 30 min.
PMA: phorbol myristate acetate.
doi:10.1371/journal.pone.0034296.t002
Figure 2. Schematic representation of the normal exon
arrangement (A) and two main splice products in the patients
(B). Italic letters represent the bp sequence at the exon 11/12 junction,
the other capital letters represent the amino acid sequences at exonic
junctions. The deletion of exons 11 and 12 does not affect a known
functional domain (A, top), but may shorten the distance between the
first SH3 domain (possibly binding to gp91-phox) and the PB1 domain
(binding to p40-phox).
doi:10.1371/journal.pone.0034296.g002
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by sequencing.
Skipping of two (or more) exons does also occur when splicing is
impaired. We detected a splice product, p67delex11,12, that was
absent from cDNA of healthy donors. This splice product was a
candidate mRNA that could possibly account for the residual
NADPH oxidase activity because it remained in frame and the
deletion did not affect a known functional domain [21,22], Fig. 2.
A transduction experiment using a retroviral vector and model
p67-CGD cells could indeed substantiate this assumption.
p67delex11,12 supports considerable ROS production (approxi-
mately 10% of normal, Table 4). This finding contrasts to
skipping of exon 5 that leaves also the p67-phox mRNA in frame,
but leads to a non-functional protein variant that is rapidly
degraded [28].
Interestingly, the exons 11 and 12 of the NCF2 gene are not
highly conserved in the evolution of vertebrates that all have
orthologues of p67-phox [29]. The genome of the lizard Anolis
carolinensis lacks exons homologous to the human exons 11 and 12,
but has exonic sequences homologous to all other human NCF2
exons that are translated (according to ENSEMBL Genomic
alignments, http://www.ensembl.org). Anolis carolinensis could be
representative for other reptiles, but this has not yet been checked.
Frogs and fish have also no homologies to exons 11 and 12, but
lack some additional homologies to human NCF2 exons.
The low residual NADPH oxidase activity in the patients in
spite of the considerable functional potential of p67delex11,12 can
be easily explained by the fact that only a small portion of aberrant
mRNA consisted of p67delex11,12. In an agarose gel, the
respective cDNA did not form a clear band, but formed
heterodimers with other splice products and was presumed by
analyzing sequence-overlays. Only the specific PCRs (Fig. 3)
revealed clearly the existence of p67delex11,12.
IFNc has been described to improve fidelity of splicing and
nuclear export of normal transcripts in a case of gp91-phox
deficient CGD caused by a splice mutation [25]. If IFNc increased
the inclusion of exon 12 into p67-phox mRNA in our case, this
would of course not enhance the production of ROS. In contrast,
an increased nuclear export of p67delex11,12 could lead to such
an improvement. However, no increase in ROS generation could
be induced by IFNc in EBV-transformed B cells from the index
patient.
From our findings we draw i) a biochemical and ii) a clinical
conclusion. i) Even though exons 11 and 12 of p67-phox are
necessary for an optimal function of the human NADPH oxidase,
the p67-phox-protein can work without the amino acid stretch
encoded by these exons. ii) Our article further contributes to the
notion that CGD should be considered at any age of patients
presenting with symptoms that fit this disorder such as severe
bacterial or fungal infections or inflammatory symptoms [6–10].
Failure to diagnose the disease can lead to progression of
complications and organ failure whereas an early diagnosis can
be prompted by adequate prophylaxis, regular check ups, and in
many cases curative hematopoietic stem cell transplantation
(HSCT). The standard prophylaxis comprises co-trimoxazole
and itraconazole. IFNc s.c. may be added irrespective of its ex
vivo impact on cells from patients [30]. Reduced intensity
conditioning HSCT is always indicated if standard prophylactic
therapy has an insufficient effect, but may be a favourable
treatment after the first severe infection or, in certain cases, even
before the first severe manifestation of CGD has occurred [31].
Materials and Methods
The patients gave written consent to blood drawing and all
diagnostic testing, including genetic analysis. Our study has been
approved by the following ethics committee: Ethik-Kommission
bei der Medizinischen Fakulta ¨t der Universita ¨t Wu ¨rzburg.
Chemiluminescence assays for NADPH Oxidase Activity
Superoxide (O2
2) production in transduced 5610
5 K562 cells
and in EBV-transformed B cells was measured by chemilumines-
cence over 45 min after stimulation with 1 mg/mL phorbol-12-
myristate-13-acetate (PMA) in a luminol-based chemilumines-
cence cocktail (Diogenes; National Diagnostics, Atlanta, GA) in a
Mithras LB 940 microplate reader (Berthold Technology, Bad
Wildbad, Germany). For patients’ neutrophils lucigenine was used
instead of the Diogenes reagent.
Determination of Flavocytochrome b558 Expression and
H2O2 Production at the Single-Cell Level
The dihydrorhodamine-1,2,3 flow cytometry assay (DHR assay)
for NADPH–oxidase-dependent production of ROS in neutro-
phils, as indicated by H2O2 production, was used as described
[24]. Staining with the monoclonal antibody (moAb) 7D5, which
specifically binds to an extracellular epitope of gp91-phox, was
performed according to standard techniques. Samples were
Figure 3. PCR with primers (Table 1) overlapping exons 10 and
13 gave amplimers only when applied to patient’s cDNA, but
not when applied to cDNA from a healthy donor. The correct
sequence of the amplimers was confirmed. Ordinate: length in bp.
doi:10.1371/journal.pone.0034296.g003
Table 3. Primers overlapping exons 10 and 13 to confirm the presence of p67delex11,12.
PCR Upstream Exon 10 Exon 13 Downstream
1 AGCAGCAGCCCCAG GAAGTRr CAGCATGAAGGATGCCTG
2 CTCCACCCAGACCGAAAACRr CCAG GAAGTGAAGCTCAGTGTT
The forward sequence of the reverse primers is shown.
doi:10.1371/journal.pone.0034296.t003
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Jose, CA).
K562 Cell Line, Culture Conditions, and Incubation of EBV
transformed B Cells with IFNc
We used a human K562 cell model of p67-phox–deficient CGD
(model p67-CGD cells) that was engineered to contain p47-phox
and gp91-phox (and that naturally expresses p22phox mRNA).
Only when K562-67def-CGD cells are transduced to also produce
p67-phox do these cells become capable of generating superoxide
in response to phorbol 12-myristate 13-acetate (PMA) stimulation
[32]. The cells were cultured in RPMI-1640 medium supple-
mented with 10% (v/v) fetal bovine serum (FBS), 2 mM
glutamine, 100 U/mL penicillin, and 0.1 mg/mL streptomycin.
EBV-transformed B cells from the index patient and a healthy
control donor were incubated with IFNc (10 or 20 ng/ml) for
seven days as described [25].
PCR and Sequencing
Genomic DNA was isolated with the QIAamp DNA Blood kit
(Qiagen, Hilden, Germany). PCR reactions were performed with
AmpliTaq Gold DNA Polymerase (Applied Biosystems, Warring-
ton, UK). DNA analysis was performed with the ABI BigDye
terminator-cycle-sequencing kit (Perkin Elmer, Weiterstadt,
Germany) and an ABI 3130XL automatic sequencer (Applied
Biosystems, Carlsbad, CA, USA). Aberrant sequences
were confirmed on both DNA strands and in a second
DNA sample to avoid PCR artifacts. The ENSEMBL NCF2
(ENSG00000116701) sequence was used.
Special primers were used for the verification of a splice product
lacking exons 11 and 12 (Table 3). A forward primer was located
in exon 10 with a 5 bp overlap into exon 13 and was combined
with a downstream reverse primer, and a reverse primer in exon
13 had a 4 bp overlap into exon 10 and was combined with an
upstream forward primer.
Retroviral Vectors and Vector Production
Full-length p67-phox-cDNA was ligated into NdeI/XhoI-
opened pET15b (Novagen; Merck Chemicals, Darmstadt, Ger-
many), to obtain pET15b-p67. To remove exons 11 and 12, we
applied overlap extension PCR and ligated the final PCR product
into AvrII/NcoI-opened pET15b-p67 to obtain pET.p67de-
lex11,12. Full-length p67-phox and p67delex11,12 were PCR
amplified and cloned into a gammaretroviral transfer vector [33]
(MFGS). Virus-particle-containing medium was from HEK 293T
cells cotransfected in 10-cm dishes with 10 mg of transfer vector
(pM.p67.iG or pM. p67delex11,12.iG), 2 mg pMD.G (vesicular
stomatitus virus glycoprotein envelope plasmid), and 6.5 mg of
pHIT60 (gagpol-packaging plasmid) in the presence of 6.75 mg/
mL polyethyleneimine. K562 cells were transduced with virus-
containing media in the presence of protamine sulfate (5 mg/mL)
and by using spinocculation (1,200 g, 30 min).
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